Macroeconomic Burden of Six Major Metabolic Diseases in Low- and Middle-Income Countries: A Value of Lost Welfare Analysis Based on the Global Burden of Disease Study 2023
This study quantifies the substantial and growing macroeconomic welfare burden of six major metabolic diseases across 120 low- and middle-income countries, revealing that these conditions cost 35.74% of total GDP in 2023, with hypertension currently dominating losses but obesity projected to drive the fastest future increase, thereby highlighting urgent needs for integrated prevention and equitable resource allocation.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
In the modern world, a quiet but powerful shift is reshaping the health of nations, particularly in places where resources are already stretched thin. This shift involves a group of conditions known as metabolic diseases. These are not sudden illnesses that strike and pass; rather, they are chronic disorders where the body's ability to process energy and nutrients falters. Think of them as a collection of related problems—including high blood pressure, excess body weight, type 2 diabetes, and issues with how the body handles fats and sugars—that often travel together. Because they develop slowly over years and frequently occur in combination, they place a heavy, long-term strain on the human body. For decades, scientists have tracked how many lives these diseases shorten or how much pain they cause. However, a new perspective is needed to understand their full impact: how much do they cost a society, not just in hospital bills, but in the lost potential of its people? This question lies at the heart of a recent study that sought to measure the invisible economic weight of these conditions across the developing world.
A team of researchers set out to answer this question by looking at 120 low- and middle-income countries, a vast region that includes nations from Asia, Africa, and Latin America. Instead of simply counting medical expenses, they used a method that translates lost health into a monetary value representing the welfare of a population. They focused on six specific metabolic conditions: type 2 diabetes, high blood pressure, obesity, high cholesterol, a liver condition linked to fat buildup, and gout. By combining data on how many healthy years of life were lost due to these diseases with the economic output of each country, the team calculated a figure they call the "value of lost welfare." This number represents the total economic value of the healthy life years that never happened because people were sick, disabled, or died too early. The study covered the period from 1990 to 2023 and used statistical models to project what might happen by the year 2050.
The results reveal a staggering economic burden. In 2023 alone, the combined welfare loss from these six diseases across these 120 countries reached 33.83 trillion international dollars. To put this in perspective, this amount is equivalent to roughly 36 percent of the total economic output, or Gross Domestic Product, of all these nations combined. This means that more than a third of the potential wealth these countries could have generated was effectively erased by the toll of metabolic disease. Among the six conditions, high blood pressure was the single largest contributor, accounting for nearly half of all these losses. It has remained the dominant driver of economic harm throughout the entire study period. However, the study also identified a rapidly changing landscape. While high blood pressure currently holds the top spot, obesity is growing at the fastest rate. The researchers project that by 2050, the economic burden of obesity will double relative to the size of these economies, signaling a dramatic shift in the nature of the crisis.
The impact of these diseases is not felt equally across all groups or regions. The study found that the relative economic hit is heaviest on lower-middle-income countries, where the loss of welfare represents a larger slice of their smaller economies. In contrast, the absolute amount of money lost is greatest in upper-middle-income nations, simply because their economies are larger to begin with. When looking at who suffers most, the burden increases sharply after age 40, peaking for people in their late 60s. Men generally face higher losses than women during their working years, but this pattern reverses in older age, with women experiencing greater losses after age 75. Geographically, the countries with the largest populations, such as China and India, recorded the highest total losses in dollar terms. Yet, when measured as a percentage of their national income, some smaller nations, including Ukraine and Egypt, faced burdens so severe that the value of lost welfare exceeded their entire annual economic output.
Looking ahead, the trajectory suggests that without significant intervention, the problem will only intensify. The researchers' projections indicate that while high blood pressure will remain the leading cause of loss through 2050, the gap between it and other conditions will narrow as obesity continues its rapid ascent. The economic strain of obesity is expected to rise from about 8 percent of national income in 2023 to more than 16 percent by mid-century. This trend reflects a broader global transition where nations are moving from fighting infectious diseases and undernutrition to grappling with the complex, long-term challenges of chronic metabolic disorders. The study highlights that these diseases are not just a health issue but a fundamental economic threat, eroding the productivity and well-being of entire populations. The authors conclude that addressing this crisis requires moving beyond treating individual diseases in isolation. Instead, they argue for integrated strategies that tackle the shared roots of these conditions, such as poor diet and inactivity, and strengthen primary healthcare systems to manage these lifelong challenges before they cause irreversible economic damage.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.